Posted 14th July 2017 by Jane Williams
A critical point in any field of research is that of commercialisation; when research builds to the point that the dam bursts, bottlenecks open and opportunities are ripe. 2016 saw the largest peak in microbiome investment since 2012 when the CRISPR-Cas9 ‘instructions’ were published.
Posted 10th April 2017 by Jane Williams
Knowledge is the key to innovation. When companies and universities collaborate to push the frontiers of knowledge, they become a powerful engine for innovation and economic growth (Santoro & Betts, 2002).
Posted 21st December 2016 by Jane Williams
At the 3rd Microbiome R&D and Business Collaboration Forum: Europe, topics covered the impact of microbiomes on human health and disease, developing therapeutics, and investment into the microbiome. Duc H. Le, the UK Editor-in-Chief of EBioMedicine, summarises some of the presentations that took place.
Posted 5th December 2016 by Jane Williams
As a start-up looking for funding, every venture capital firm might seem the same, but all money is not created equal. When you present yourself to a venture capitalist, you’re selling to a business. This means you need to get to know their business and what motivates their decision-makers.
Posted 14th November 2016 by Jane Williams
The vast amount of research into the human microbiome is attracting new companies to the field and the race to translate scientific data into viable products has begun. Financial interest in the microbiome is at an all-time high, giving many scientists the opportunity to start their own business as product development or service companies.